Learning Objectives ~ upon conclusion of this program, participants should be able to:

• Recognize potential targets for novel lung cancer drugs and available novel agents to treat lung cancer

• Recongize the biology and mechanism of action of Antibody Drug Conjugates

• Identify the role of Kras mutations in lung cancer and novel approaches to inhibiting Kras

Date/Time: Friday, November 9, 2018 | 12:15 – 1:15 PM

Alex A. Adjei, M.D., Ph.D.

Consultant, Medical Oncology 

Professor of Oncology and Pharmacology, College of Medicine

Mayo Clinic, Rochester, MN

MMI Presentation:  Sabirah Kasule, MD – Resident, Internal Medicine

LOCATIONS:  Phoenix Campus, Mayo Clinic Hosptal Waugh Auditorium, Side A | Phoenix Campus, Mayo Clinic Hospital, MH 1-212 and MH 01 115 | Scottsdale Campus, Mayo Clinic Building - Taylor Auditorium } | Other video conf locations: Mayo Clinic Primary Care-Phoenix Campus, Mayo Clinic Women's Health Internal Medicine-Thunderbird, Mayo Clinic Family Medicine-Arrowhead, Canyon Ranch Medicine Center, San Tan Medical Center

To receive CME credit and record attendance, text the unique presentation code to 507-200-3010 
Trainees must ALSO swipe to record their attendance.  Attendees must be present to receive code.

ABOUT Internal Medicine Grand Rounds are held weekly on Fridays for all physicians and allied health staff.

ADDITIONAL INFORMATION Lunch will be served on the Scottsdale and Phoenix campuses only.

ARCHIVED PRESENTATIONS Located in Internal Medicine, Department of -ARZ  video library at http://intranet.mayo.edu/charlie/internal-medicine-arz/home/archived-grand-rounds/.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.